Srinivas Ganneboina

Srinivas Ganneboina

Active Director Director DIN 08205281
DIN 08205281 First appointment Aug 2018 Primary industry Chemicals
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Aug 2018
Shareholding value β€’β€’β€’β€’ Premium profile

About Srinivas Ganneboina

Data last updated:

Srinivas Ganneboina is a Director at Lerasa Pharmaceuticals Private Limited (since 2018). The company operates in Chemicals.

DIN 08205281
Primary Designation Director
Industry Chemicals
First Appointment 23 Aug 2018
Oldest Company Age 8 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director23 Aug 20182018Active

Board colleagues of Srinivas Ganneboina

NameDINCompanyDesignation
Shobha Rani Moodu08205282Lerasa Pharmaceuticals Private LimitedDirector

Directorship timeline

Open interactive timeline →
Lerasa Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Srinivas Ganneboina

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Srinivas Ganneboina

Srinivas Ganneboina currently holds 1 directorship: Lerasa Pharmaceuticals Private Limited (Director, since 23 Aug 2018).

Srinivas Ganneboina was first appointed on 23 Aug 2018 as Director at Lerasa Pharmaceuticals Private Limited.

The current boards of Srinivas Ganneboina's companies include Shobha Rani Moodu (Lerasa Pharmaceuticals Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available